{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1605132", "DateCompleted": {"Year": "1992", "Month": "07", "Day": "15"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "18"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0192-415X", "JournalIssue": {"Volume": "20", "Issue": "1", "PubDate": {"Year": "1992"}}, "Title": "The American journal of Chinese medicine", "ISOAbbreviation": "Am J Chin Med"}, "ArticleTitle": "Effects of \"kyushin\", a drug containing toad venom, on experimental congestive heart failure in rabbits.", "Pagination": {"StartPage": "83", "EndPage": "89", "MedlinePgn": "83-9"}, "Abstract": {"AbstractText": ["Effects of \"Kyushin\" (KY-2), a drug containing toad venom, on a low-output-type heart failure model produced in rabbits by protease treatment on the left ventricular anterior wall, were examined. Heart rate, aortic blood flow (AoF), left ventricular systolic pressure (LVP) and maximal rate of rise of LVP (max dP/dt) in this model were maintained at lower levels than those in normal rabbits, while left ventricular end-diastolic pressure (LVEDP) and systemic vascular resistance (SVR) were maintained at higher levels, and the mean blood pressure (MBP) was at a normal level. KY-2 was administered intraduodenally to the animal. KY-2 improved heart failure state by increasing the AoF, LVP and max dP/dt, and by decreasing the LVEDP and SVR without a significant change in MBP. These results suggest that the beneficial effects of KY-2 on this heart failure model originate from their cardiotonic activity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Laboratories, Kyushin Pharmaceutical Co., Ltd., Tokyo, Japan."}], "LastName": "Morishita", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Shoji", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Oguni", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ito", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Noguchi", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sakanashi", "ForeName": "M", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Singapore", "MedlineTA": "Am J Chin Med", "NlmUniqueID": "7901431", "ISSNLinking": "0192-415X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amphibian Venoms"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Amphibian Venoms"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["drug therapy", "mortality", "physiopathology"], "DescriptorName": "Heart Failure"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemodynamics"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["physiology"], "DescriptorName": "Panax"}, {"QualifierName": ["physiology"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rabbits"}, {"QualifierName": [], "DescriptorName": "Survival Rate"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1992", "Month": "1", "Day": "1"}, {"Year": "1992", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1605132", "10.1142/S0192415X92000096", "S0192415X92000096"]}}]}